EP4415783A2 — Autoinjection device
Assigned to Congruence Medical Solutions LLC · Expires 2024-08-21 · 2y expired
What this patent protects
Autoinjector including a compressed gas source including a rigid container having a non-rigid sealing structure, and a syringe with a plunger stopper and a seal defining an actuation space between the plunger stopper and the seal. The autoinjector further includes a puncturing ne…
USPTO Abstract
Autoinjector including a compressed gas source including a rigid container having a non-rigid sealing structure, and a syringe with a plunger stopper and a seal defining an actuation space between the plunger stopper and the seal. The autoinjector further includes a puncturing needle fluidly coupled to or coupleable to the actuation space. The puncturing needle further being axially aligned to selectively penetrate the non-rigid sealing structure of the compressed gas source upon relative axial movement therebetween to fluidly couple the puncturing needle with the compressed gas source.
Drugs covered by this patent
- Epipen (epinephrine) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.